IP Library Patent Application 17835051
Patent Application
App. No. 17/835,051

18-MC FOR TREATING OBESITY

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
17/835,051
Abstract

A method of treating obesity, by administering an effective amount of a composition chosen from the group consisting of 18-methoxycoronaridine (18-MC), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, and deuterated forms thereof to an individual and treating obesity. A method of treating binge eating, by administering an effective amount of the composition to an individual and treating binge eating. A method of treating behavioral addictions, by administering an effective amount of the composition to an individual and treating the behavioral addiction.

Claims (22)

1 . A method of treating obesity, including the steps of:

administering an effective amount of a composition chosen from the group consisting of 18-methoxycoronaridine (18-MC), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, and deuterated forms thereof to an individual; and

treating obesity.

2 . The method of claim 1 , wherein the composition is administered in a dose of 0.01-10 mg/kg.

3 . The method of claim 1 , wherein the composition is administered as a single dose.

4 . The method of claim 1 , wherein the composition is administered as a repeat dose over a time period chosen from the group consisting of days, weeks, months, and years.

5 . The method of claim 1 , wherein said treating step further includes the steps of reducing craving for food and reducing weight gain in the individual.

6 . A method of treating binge eating, including the steps of:

administering an effective amount of a composition chosen from the group consisting of 18-methoxycoronaridine (18-MC), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, and deuterated forms thereof to an individual; and

treating binge eating.

7 . The method of claim 6 , wherein the composition is administered in a dose of 0.01-10 mg/kg.

8 . The method of claim 6 , wherein the composition is administered as a single dose.

9 . The method of claim 6 , wherein the composition is administered as a repeat dose over a time period chosen from the group consisting of days, weeks, months, and years.

10 . The method of claim 6 , wherein said treating step further includes the step of reducing craving for food in the individual.

11 . A method of treating behavioral addictions, including the steps of:

administering an effective amount of a composition chosen from the group consisting of 18-methoxycoronaridine (18-MC), salts thereof, tartrates thereof, solvates thereof, isomers thereof, analogs thereof, homologues thereof, and deuterated forms thereof to an individual; and

treating the behavioral addiction.

12 . The method of claim 11 , wherein the behavioral addiction is chosen from the group consisting of gambling, sex, food, plastic surgery, social media, internet, risks, shopping, and pornography.

13 . The method of claim 11 , wherein said treating step further includes the steps of reducing and/or eliminating a need to do behaviors relating to the behavioral addiction.

14 . The method of claim 11 , wherein the composition is administered in a dose of 0.01-10 mg/kg.

15 . The method of claim 11 , wherein the composition is administered as a single dose.

16 . The method of claim 11 , wherein the composition is administered as a repeat dose over a time period chosen from the group consisting of days, weeks, months, and years.

Assignments (2)
CHANGE OF NAME Recorded Jan 26, 2026
From: MIND MEDICINE, INC.
To: DEFINIUM THERAPEUTICS US, INC.
Reel/Frame 074489/0176 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2022
From: BARROW, ROBERT; KARLIN, DANIEL R.
To: MIND MEDICINE, INC.
Reel/Frame 060216/0780 →